Apo-B [II AC 9/14 (64.2 %)], [II AC-T 2/12 (16.6 %)], [IV AC 9/15 (60 %)] and [IV AC-T 2/15 (13.3 %)] of breast cancer cases using a cut-off point 60-117 mg/dl (Apo-B). This evidence concerns the gene APOB and breast carcinoma.